Deerfield Group

Canaccord Genuity Advises Deerfield Group on its Acquisition of Triple Threat Communications

Combined team brings together 200+ experts driving expansion of comprehensive, integrated marketing and communications solutions for leading pharma, biotech, and life sciences organizations at every stage and size

Canaccord Genuity has advised Deerfield Group on its acquisition of Triple Threat Communications (TTC). The acquisition augments Deerfield’s existing marketing, communications, media, and data analytics capabilities with greater depth in strategy, creative, digital, and medical communications. Tim Frank, TTC’s owner and managing partner, will join Deerfield’s executive leadership team and continue to lead client business across the agency.

Deerfield Group is a full-service integrated marketing, advertising, and communications agency providing innovative solutions for pharmaceutical, biotechnology, health tech, and consumer health companies. Deerfield’s solutions are designed to meet the unique needs of healthcare organizations at all stages of their life cycles. At the core of the agency’s philosophy is the science of storytelling, powered by data-driven insights to deliver measurable results for clients. The company provides a full spectrum of marketing and communications services, including insights and strategy, creative and digital, omnichannel marketing, media, public relations, data and analytics, sales enablement, and print management. Deerfield’s Agency of Brand® model integrates these offerings to deliver full-service marketing and digital solutions at scale. Deerfield Group is a portfolio company of The Edgewater Funds, a Chicago-based private equity firm with more than $4 billion of capital commitments.

Established in 2005, TTC is known for its award-winning client service, creative, editorial, and production services, supporting a portfolio of mid-size and large pharmaceutical companies in the U.S. and globally. The team’s seasoned experts and distinct-yet-complementary expertise further elevates Deerfield’s position as a trusted agency partner and is expected to support future growth and business development opportunities. 

The TTC acquisition is the latest strategic investment by Deerfield, including the successful integrations of Verge Scientific Communications and Embedded in 2022 and 2024, respectively. These additions have propelled the agency to deliver integrated marketing and communications services and counsel to a growing portfolio of clients from early-stage biotech to commercialized pharmaceutical companies. Deerfield was recently ranked 38th in MM&M’s Agency 100 rankings, with 31 percent growth in 2024.